Phosphatidylinositol 4,5-bisphosphate-specific AKT1 is oncogenic
Open Access
- 28 October 2009
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 127 (1), 239-244
- https://doi.org/10.1002/ijc.25012
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- A distinct pool of phosphatidylinositol 4,5-bisphosphate in caveolae revealed by a nanoscale labeling techniqueProceedings of the National Academy of Sciences of the United States of America, 2009
- The oncogenic mutation in the pleckstrin homology domain of AKT1 in endometrial carcinomasBritish Journal of Cancer, 2009
- Inhibitor hijacking of Akt activationNature Chemical Biology, 2009
- 3-D structure and dynamics of protein kinase B—new mechanism for the allosteric regulation of an AGC kinaseJournal of Chemical Biology, 2009
- A new evaluation method for quantifying PI3K activity by HTRF assayBiochemical and Biophysical Research Communications, 2008
- Molecular Mechanism of an Oncogenic Mutation That Alters Membrane Targeting: Glu17Lys Modifies the PIP Lipid Specificity of the AKT1 PH DomainBiochemistry, 2008
- A transforming mutation in the pleckstrin homology domain of AKT1 in cancerNature, 2007
- Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancersNature Genetics, 1997
- PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate CancerScience, 1997
- The identification of a novel inositol lipid, phosphatidylinostiol trisphosphate (PIP3), in rat cerebrum using in vivo techniquesBiochemical and Biophysical Research Communications, 1989